Wilson & Boucher Capital Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$336K Hold
4,403
0.22% 87
2025
Q4
$281K Hold
4,403
0.18% 95
2025
Q3
$278K Hold
4,403
0.18% 96
2025
Q2
$329K Hold
4,403
0.23% 91
2025
Q1
$388K Sell
4,403
-200
-4% -$18.9K 0.29% 84
2024
Q4
$420K Hold
4,603
0.3% 80
2024
Q3
$515K Hold
4,603
0.36% 74
2024
Q2
$451K Hold
4,603
0.35% 75
2024
Q1
$461K Hold
4,603
0.36% 74
2023
Q4
$413K Hold
4,603
0.35% 76
2023
Q3
$353K Hold
4,603
0.34% 76
2023
Q2
$385K Hold
4,603
0.35% 72
2023
Q1
$388K Hold
4,603
0.37% 72
2022
Q4
$375K Sell
4,603
-100
-2% -$8.06K 0.38% 70
2022
Q3
$334K Hold
4,703
0.39% 72
2022
Q2
$422K Hold
4,703
0.46% 66
2022
Q1
$527K Hold
4,703
0.48% 61
2021
Q4
$569K Buy
+4,703
New +$523K 0.51% 59

Other funds holding EMN

Wilson & Boucher Capital Management's EMN Position: Q1 2026 in Review

Wilson & Boucher Capital Management held its Eastman Chemical (EMN) position steady in Q1 2026 at 4,403 shares worth $336K. The position accounts for 0.22% of the portfolio, ranked #87.

Wilson & Boucher Capital Management first reported a position in EMN in Q4 2021 and has held it in 18 quarters since. The position peaked at $569K in Q4 2021. 635 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Wilson & Boucher Capital Management held 4,403 shares of Eastman Chemical worth $336K as of Q1 2026.
  • Wilson & Boucher Capital Management left its Eastman Chemical share count unchanged in Q1 2026.
  • Eastman Chemical made up 0.22% of Wilson & Boucher Capital Management's portfolio in Q1 2026, its #87 holding.
  • Wilson & Boucher Capital Management first reported a position in Eastman Chemical in Q4 2021 and has held it in 18 quarters since.
  • Wilson & Boucher Capital Management's Eastman Chemical position peaked at $569K in Q4 2021.
  • 635 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Wilson & Boucher Capital Management's 13F filing for Q1 2026, filed 18 May 2026.